ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 144 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $508,800 | -90.4% | 320,000 | -94.3% | 0.06% | -92.1% |
Q3 2022 | $5,308,000 | +438.3% | 5,587,789 | +5488.2% | 0.72% | +305.1% |
Q1 2021 | $986,000 | -33.1% | 99,992 | -26.5% | 0.18% | -8.2% |
Q4 2020 | $1,474,000 | -60.7% | 135,992 | -62.7% | 0.19% | -90.2% |
Q3 2020 | $3,753,000 | -17.8% | 364,349 | +66.6% | 1.99% | -23.6% |
Q2 2020 | $4,566,000 | +48.9% | 218,723 | -30.3% | 2.60% | -27.1% |
Q1 2020 | $3,067,000 | -22.3% | 313,900 | -8.4% | 3.57% | -6.3% |
Q4 2019 | $3,949,000 | – | 342,800 | – | 3.81% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |